Entera Bio Ltd. ENTX and OPKO Health, Inc. OPK recently announced positive topline pharmacokinetic/pharmacodynamic (PK/PD) results from their ongoing collaborative ...

OPK Health, Inc. OPK and Entera Bio Ltd. ENTX recently announced the positive pharmacokinetic outcomes from their joint study that combines Entera's exclusive N-Tab technology with a long-acting, ...

We recently compiled a list of the 10 Best Stocks Under $3 to Buy Now. In this article, we are going to take a look at where ...

Diversified healthcare company OPKO Health Inc. OPK announced failure in its data analysis of the Phase 3 Clinical Study of hGH-CTP in Growth Hormone Deficient Adults. The study of hGH-CTP in adults ...

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. OPKO Health, Inc. is one of them. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with ...

Opko Health Inc. (NASDAQ:OPK) is one of the best stocks under $5 with highest upside potential. ModeX Therapeutics Inc., an Opko Health Inc. (NASDAQ:OPK) company, announced on October 29 a license and ...

Rayaldee EU Approval is close and the clinical trial as a COVID therapeutic is underway. Pipeline star Somatrogon, the weekly human growth hormone drug, prepares for FDA BLA submission with partner ...

OPKO Health, Inc. ( OPK) announced positive top-line results from the second and final pivotal phase III trial on Rayaldee. OPKO Health is conducting the trial to establish the safety and efficacy of ...

Good afternoon, and welcome to the OPKO Health First Quarter 2025 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, ...